News & Events
News and Upcoming Events
InDevR Raises $9 Million in Series B Financing and Partners with bioMérieux
Boulder, CO, 17 January 2023 – InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant ...
Read More
Read More
Vaccines Research & Development – November 7-9, 2022
InDevR will be presenting an Exhibitor Talk on November 7 at 12:50 - 1:00 pm ET. Speaker: April Blodgett To see our talk, visit the booth, and learn more about ...
Read More
Read More
Past News and Events
GEN Webinar: Speed and Simplicity for mRNA Vaccines and Therapeutics CQA Testing Register to view the webinar Speaker: Kathy Rowlen, PhD Title: CEO & Co-founder InDevR Bio: Dr. Kathy Rowlen ...
Read More
Read More
CHI Webinar – Aug 25th, 2022: Assessing neuraminidase presence in influenza vaccines using InDevR’s VaxArray Platform Register to view the webinar Speaker: Jeff Pederson, Ph.D. Title: Global Head, Analytical Science ...
Read More
Read More
InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization BOULDER, Colo., May 10, 2022 (Newswire.com) - InDevR, Inc., a life science tools company providing powerful analytical technologies to support the ...
Read More
Read More
On-Demand WVC Webinar - May 10th, 2022: New CQA Test Kits for Multivalent Influenza Vaccines: 1 Hour Assay Provides Multiplexed Identity, Quantity, and Stability Testing We Invite you to our ...
Read More
Read More
World Vaccine Congress - April 18-21 2022 InDevR will be exhibiting and giving a short talk at the World Vaccine Congress. Talk Title: Identity, Quantity, and Integrity Characterization of Multivalent ...
Read More
Read More
World Antiviral Congress - November 30 to December 2, 2021 InDevR will be exhibiting and giving a short talk at the World Antiviral Congress. The talk is titled " Customer ...
Read More
Read More
